Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Murdoch

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Clinical & Experimental Ophthalmology|July 18, 2002
Acquired hyperopia with choroidal foldsDavid Murdoch, Michael Merriman
The British Journal of Cardiology|June 24, 2022
Real-life outcomes and readmissions after a TAVI procedure in a Glasgow populationJoanna Osmanska, David Murdoch
CNS Drugs|February 16, 2006
Spotlight on escitalopram in the management of major depressive disorderDavid Murdoch, Susan J Keam
Drugs|April 20, 2006
Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillationDavid Murdoch, Greg L Plosker
Drugs|October 1, 2004
AnidulafunginDavid Murdoch, Greg L Plosker
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemiaDavid Murdoch, Lesley J Scott
CNS Drugs|March 15, 2006
Sertindole : a review of its use in schizophreniaDavid Murdoch, Gillian M Keating
Drugs|November 4, 2005
Escitalopram: a review of its use in the management of major depressive disorderDavid Murdoch, Susan J Keam
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 7, 2005
Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosisDavid Murdoch, Katherine A Lyseng-Williamson
Drugs|May 27, 2005
Subcutaneous recombinant interferon-beta-1a (Rebif): a review of its use in relapsing-remitting multiple sclerosisDavid Murdoch, Katherine A Lyseng-Williamson
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Clinical & Experimental Ophthalmology|July 18, 2002
Acquired hyperopia with choroidal foldsDavid Murdoch, Michael Merriman
The British Journal of Cardiology|June 24, 2022
Real-life outcomes and readmissions after a TAVI procedure in a Glasgow populationJoanna Osmanska, David Murdoch
CNS Drugs|February 16, 2006
Spotlight on escitalopram in the management of major depressive disorderDavid Murdoch, Susan J Keam
Drugs|April 20, 2006
Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillationDavid Murdoch, Greg L Plosker
Drugs|October 1, 2004
AnidulafunginDavid Murdoch, Greg L Plosker
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|November 24, 2004
Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemiaDavid Murdoch, Lesley J Scott
CNS Drugs|March 15, 2006
Sertindole : a review of its use in schizophreniaDavid Murdoch, Gillian M Keating
Drugs|November 4, 2005
Escitalopram: a review of its use in the management of major depressive disorderDavid Murdoch, Susan J Keam
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 7, 2005
Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosisDavid Murdoch, Katherine A Lyseng-Williamson
Drugs|May 27, 2005
Subcutaneous recombinant interferon-beta-1a (Rebif): a review of its use in relapsing-remitting multiple sclerosisDavid Murdoch, Katherine A Lyseng-Williamson
Pageof 6